NEFSX
Price
$43.39
Change
-$0.19 (-0.44%)
Updated
Jun 5 closing price
Net Assets
1.16B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

NEFSX vs VITSX

Header iconNEFSX vs VITSX Comparison
Open Charts NEFSX vs VITSXBanner chart's image
Natixis US Equity Opportunities A
Price$43.39
Change-$0.19 (-0.44%)
VolumeN/A
Net Assets1.16B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
NEFSX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NEFSX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEFSX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. NEFSX (1.16B). VITSX pays higher dividends than NEFSX: VITSX (1.29) vs NEFSX (0.09). NEFSX was incepted earlier than VITSX: NEFSX (31 years) vs VITSX (28 years). NEFSX (1.07) is less costly to investors than VITSX (0.03). NEFSX is a more actively managed with annual turnover of: 33.00 vs. VITSX (2.00). NEFSX has a lower initial minimum investment than VITSX: NEFSX (2500) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. NEFSX (8.85). VITSX return over 5 years is better than : 80.96 vs. NEFSX (20.06).
NEFSXVITSXNEFSX / VITSX
Total Expense Ratio1.070.033,567%
Annual Report Gross Expense Ratio1.070.033,567%
Fund Existence31 years28 years-
Gain YTD0.3010.83336%
Front Load6%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.16B1.82T0%
Annual Yield % from dividends0.091.297%
Returns for 1 year8.8510.9781%
Returns for 3 years23.4740.3558%
Returns for 5 years20.0680.9625%
Returns for 10 years55.45180.4931%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.